reference/330392

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/330392

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	1471-2407
issueIdentifier	1
pageRange	63-
publicationName	BMC Cancer
startingPage	63
bibliographicCitation	Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy. BMC Cancer. 2007 Apr 12;7():63. PMID: 17430582; PMCID: PMC1863427.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d98f5b4132c92bbad239589139a7ed0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bdc894c4e7fc938881b030d71c6ed6ab http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9219-3350 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5afe11089fe1a36156fe1817e6cc6b98 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58b8568d18eb465cec02d76659b2a216 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65b4915fc977f76d2f9754caf41b7a00 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dce68b61044e581129b4e52f14a01e6b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3f2cd76bcd147aa52c0447393dc8493 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_389576ad3e988a867bbb8cd2adddebdd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2153c88db5da839197449f42e2b3dee4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc5ec49e3e3e1156ca481cf5592805c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b70a60c31f8f73cd19eda094faddaa76 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_468d416003fbc9bd2e024f8a6e1b89a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d39351cc6782ecb659ccd0b06ffc01af
date	2007-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/17430582 https://pubmed.ncbi.nlm.nih.gov/PMC1863427 https://doi.org/10.1186/1471-2407-7-63
isPartOf	https://portal.issn.org/resource/ISSN/1471-2407 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
discusses	http://id.nlm.nih.gov/mesh/M0028859 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0024670 http://id.nlm.nih.gov/mesh/M0021024 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0028673 http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0026156 http://id.nlm.nih.gov/mesh/M0028048 http://id.nlm.nih.gov/mesh/M0018586 http://id.nlm.nih.gov/mesh/M0018613
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f3366af2ce1555e259faab86aad3bef http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7559 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1b2452da84551fc91db93425b6a20d9 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e1afa113b0d884f36154ce9339375de8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a517e173e6fa70285ded085be0d86f http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128482492 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129138006 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127676247 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128713593

Total number of triples: 60.